Back to GILD

Rhenman & Partners Asset Management AB → GILD

Rhenman & Partners Asset Management AB GILD Position History

Gilead Sciences, Inc. • Healthcare

Quarters held
4
Latest value
$23.7M
Q3 2026
Peak value
$23.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$15.5M
Q1 2026$23.4M
Q2 2026$22.5M
Q3 2026$23.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$23.7M159.1K——
Q2 2026$22.5M178.3K——
Q1 2026$23.4M167.8K——
Q4 2025$15.5M126.2K——

Other funds holding GILD

Other Rhenman & Partners Asset Management AB positions

REGN

REGENERON PHARMACEUTICALS

$47.4M
LLY

LILLY ELI & CO

$45.4M
BSX

BOSTON SCIENTIFIC CORP

$41.1M
BSX

BOSTON SCIENTIFIC CORP

$39.2M
UNH

UNITED HEALTH GROUP INC

$38.9M
REGN

REGENERON PHARMACEUTICALS

$37.2M
JPM-PM

IOVANCE BIOTHERAPEUTICS INC

$37.1M
LLY

LILLY ELI & CO

$31M